Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giampietro Corradin

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Microbes and Infection|April 3, 2007
Peptide based malaria vaccine development: personal considerationsGiampietro Corradin
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 13, 2002
Malaria vaccines: from the laboratory to the fieldBlaise Genton, Giampietro Corradin
Ebiomedicine|July 3, 2015
Malaria Vaccines: Progressing on a Bumpy RoadGiampietro Corradin, Issa Nebie
Frontiers in Immunology|November 22, 2014
Priming of CD8(+) T Cell Responses to Liver Stage Malaria Parasite AntigensGiampietro Corradin, Jelena Levitskaya
Expert Review of Vaccines|January 30, 2010
Malaria vaccine: why is it taking so long?Giampietro Corradin, Andrey V Kajava
Expert Opinion on Biological Therapy|October 6, 2004
Medicinal application of long synthetic peptide technologyGiampietro Corradin, Francois Spertini, Antonio Verdini
Methods in Molecular Medicine|July 20, 2002
Peptide vaccinationValentin Meraldi, Jackeline F Romero, Giampietro Corradin
Trends in Parasitology|January 30, 2007
An update on the search for a Plasmodium vivax vaccineSócrates Herrera, Giampietro Corradin, Myriam Arévalo-Herrera
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
IL-12 administration leads to a transient depletion of T cells, B cells, and APCs and concomitant abrogation of the HLA-A2.1-restricted CTL response in transgenic miceKatrin Peter, Michael J Brunda, Giampietro Corradin
Endocrine, Metabolic & Immune Disorders Drug Targets|January 29, 2008
Protein structure based strategies for antigen discovery and vaccine development against malaria and other pathogensGiampietro Corradin, Viviane Villard, Andrey V Kajava
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Microbes and Infection|April 3, 2007
Peptide based malaria vaccine development: personal considerationsGiampietro Corradin
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|December 13, 2002
Malaria vaccines: from the laboratory to the fieldBlaise Genton, Giampietro Corradin
Ebiomedicine|July 3, 2015
Malaria Vaccines: Progressing on a Bumpy RoadGiampietro Corradin, Issa Nebie
Frontiers in Immunology|November 22, 2014
Priming of CD8(+) T Cell Responses to Liver Stage Malaria Parasite AntigensGiampietro Corradin, Jelena Levitskaya
Expert Review of Vaccines|January 30, 2010
Malaria vaccine: why is it taking so long?Giampietro Corradin, Andrey V Kajava
Expert Opinion on Biological Therapy|October 6, 2004
Medicinal application of long synthetic peptide technologyGiampietro Corradin, Francois Spertini, Antonio Verdini
Methods in Molecular Medicine|July 20, 2002
Peptide vaccinationValentin Meraldi, Jackeline F Romero, Giampietro Corradin
Trends in Parasitology|January 30, 2007
An update on the search for a Plasmodium vivax vaccineSócrates Herrera, Giampietro Corradin, Myriam Arévalo-Herrera
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
IL-12 administration leads to a transient depletion of T cells, B cells, and APCs and concomitant abrogation of the HLA-A2.1-restricted CTL response in transgenic miceKatrin Peter, Michael J Brunda, Giampietro Corradin
Endocrine, Metabolic & Immune Disorders Drug Targets|January 29, 2008
Protein structure based strategies for antigen discovery and vaccine development against malaria and other pathogensGiampietro Corradin, Viviane Villard, Andrey V Kajava
Pageof 9